We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.
The current ALGEN market cap is 36.54M. The company's latest EPS is EUR 0.0839 and P/E is 46.96.
| Year End December 30 2022 | 2018 | 2019 | 2020 | 2021 | 2022 |
|---|---|---|---|---|---|
| EUR (€) | EUR (€) | EUR (€) | EUR (€) | EUR (€) | |
| Total Revenue | 14.03M | 13.02M | 14.51M | 17.92M | 19.8M |
| Operating Income | 603k | -641k | -307k | -530k | 991k |
| Net Income | 571k | -1.04M | -687k | -322k | 778k |
| Year End December 30 2022 | 2018 | 2019 | 2020 | 2021 | 2022 |
|---|---|---|---|---|---|
| EUR (€) | EUR (€) | EUR (€) | EUR (€) | EUR (€) | |
| Total Assets | 19.69M | 19.15M | 27.57M | 32.66M | 32.92M |
| Total Liabilities | 11.8M | 12.31M | 18.57M | 17.94M | 16.76M |
| Total Equity | 7.89M | 6.84M | 9M | 14.72M | 16.17M |
| Year End December 30 2022 | 2018 | 2019 | 2020 | 2021 | 2022 |
|---|---|---|---|---|---|
| EUR (€) | EUR (€) | EUR (€) | EUR (€) | EUR (€) | |
| Operating | N/A | N/A | -163k | -561k | N/A |
| Investing | N/A | N/A | -4.75M | -2.26M | N/A |
| Financing | N/A | N/A | 6.54M | 5.71M | N/A |
| Market Cap | 36.54M |
| Price to Earnings Ratio | 46.96 |
| Price to Sales Ratio | 1.85 |
| Price to Cash Ratio | 7.49 |
| Price to Book Ratio | 2.26 |
| Dividend Yield | - |
| Shares Outstanding | 9.27M |
| Average Volume (1 week) | 6.06k |
| Average Volume (1 Month) | 8.78k |
| 52 Week Change | 4.79% |
| 52 Week High | 4.91 |
| 52 Week Low | 3.50 |
| Spread (Intraday) | 0.04 (1.01%) |
| Company Name | Genoway S A Inh Eo 15 |
| Address |
31 rue saint jean de dieu lyon, rhone 69007 |
| Website | https://www.genoway.com |
| Industry | pharmaceutical preparations (2834) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: 1-888-992-3836 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
